Colorectal CancerNCT07289685
Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery
An observational study of Colorectal Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement. Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. Read more about this study
- Who is it for?
- Ages 20 to 85 years
- Conditions the study is for
- Colorectal Cancer
- How many people
- 192 participants
- Where
- 1 siteTaiwan
- Study dates
- 8 Aug 2022to 8 Jan 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 85 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults aged 20 to 85 years diagnosed with colorectal cancer who underwent minimally invasive surgery at a medical center. Patients must be able to communicate in Mandarin or Taiwanese and provide informed consent.
Who may be able to join
- Patients undergoing minimally invasive colorectal tumor resection.
- Aged 20 to 85 years.
- ECOG score 0-2.
- Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
- Informed consent provided by the patient or family.
Who cannot join
- Patients with acute/chronic psychiatric disorders or cognitive impairment.
- Patients undergoing traditional open or local resection surgeries.
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement.
Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs.
Read more
Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care.
The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.
- Conditions
- Colorectal Cancer
- Medical subject headings
- Colorectal Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Postoperative Colorectal Cancer Patients with Wearable Device Monitoring | Patients diagnosed with colorectal cancer who underwent minimally invasive surgery. Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospital Length of Stay
The number of calendar days from the date of colorectal surgery to the date of hospital discharge, recorded from the hospital electronic medical record.
Measured: Through hospital discharge (an average of 7 days after surgery)
Secondary outcomes (1)
Postoperative Complications (Clavien-Dindo classification)
The occurrence and severity of postoperative complications during hospitalization, graded using the Clavien-Dindo classification system based on medical record review.
Measured: Postoperative Day 30
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Dec 2025
- Study start8 Aug 2022
- Primary completion5 Jan 2024
- Study completion8 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- More trials run by Chang Gung Memorial HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 192 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07289685
- Sponsor's protocol ID
- 202102412B0
- Other IDs
- CMRPG3M2171
- Status last verified
- Aug 2025
- First submitted
- 20 Aug 2025
- Last updated
- 17 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual Participant Data (IPD) will not be shared due to the need to protect patient privacy and confidentiality. Additionally, there are no current plans for secondary analysis or collaboration with external researchers.
Study at a glance
From the registry record, last updated by the sponsor on 17 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery
- ClinicalTrials.gov ID
- NCT07289685
- Acronym / sponsor ID
- 202102412B0
- Conditions
- Colorectal Cancer
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 192 participants (actual)
- Lead sponsor
- Chang Gung Memorial HospitalUniversity, hospital or other
- Study start
- 8 Aug 2022 (actual)
- Primary completion
- 5 Jan 2024 (actual)
- Study completion
- 8 Jan 2024 (actual)
- First posted
- 17 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement.
Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs.
Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care.
The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Postoperative Colorectal Cancer Patients with Wearable Device Monitoring | – | –Patients diagnosed with colorectal cancer who underwent minimally invasive surgery. Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge. |
Who may qualify
- Ages
- 20 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults aged 20 to 85 years diagnosed with colorectal cancer who underwent minimally invasive surgery at a medical center. Patients must be able to communicate in Mandarin or Taiwanese and provide informed consent.
Key inclusion criteria (5 listed)
- Patients undergoing minimally invasive colorectal tumor resection.
- Aged 20 to 85 years.
- ECOG score 0-2.
- Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
- Informed consent provided by the patient or family.
Key exclusion criteria (2 listed)
- Patients with acute/chronic psychiatric disorders or cognitive impairment.
- Patients undergoing traditional open or local resection surgeries.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Hospital Length of Stay
Time frame: Through hospital discharge (an average of 7 days after surgery)
The number of calendar days from the date of colorectal surgery to the date of hospital discharge, recorded from the hospital electronic medical record.
1 secondary outcome
Postoperative Complications (Clavien-Dindo classification)
Time frame: Postoperative Day 30
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Dec 2025.
- Individual participant dataSharing planned: No. Individual Participant Data (IPD) will not be shared due to the need to protect patient privacy and confidentiality. Additionally, there are no current plans for secondary analysis or collaboration with external researchers.
Related trials for Colorectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingObservational study
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Rectal Neoplasms
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hospital Length of Stay (time frame: Through hospital discharge (an average of 7 days after surgery)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2025.